 CLEVELAND, Sept. 29, 2021 PRNewswire -- ViewRay, Inc. NASDAQ: VRAY today announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility. 